DisneyFan32
Well-Known Member
- In the Parks
- Yes
MSN
www.msn.com
A day after announcing New Jersey has recorded its first case of the omicron COVID-19 variant, Gov. Phil Murphy told NJ Advance Media on Saturday that many more cases are likely to hit the state.
Murphy also stressed that “early evidence” suggests the variant is more transmissible but tends to come with moderate symptoms — though he called on residents to remain “vigilant” by taking health precautions.
“As we were saying for the past week, we just assumed it was in our state,” the governor said during a short interview after an unrelated event in Carteret. “My gut tells me this is the first of many to come.”
Though Murphy said “the science is incomplete” on the variant, the “early sense” is that it’s “much more transmissible, including to folks that have already been infected.”
“But again, I almost don’t want to say this, but please God it’s true, early evidence is the impacts are mild,” Murphy said. “I know the one case in New Jersey is mild symptoms.
“But that is incomplete,” he added. “So folks need to be vigilant, wearing the masks, getting vaccinated, getting boosted. Because so far at least, there’s no evidence that lineup is not working.”
The state’s first case was discovered in an adult Georgia woman who traveled to New Jersey recently after traveling to South Africa, officials said. Her identity not been revealed.
The woman, who is fully vaccinated against COVID-19, tested positive Nov. 28, has been in isolation since, and has experienced moderate symptoms, officials said. She is receiving care in the emergency department of an unidentified North Jersey hospital, they said.
Asked Saturday where her case was identified, where she is recovering in the state, and whether she was taking a trip to New Jersey, Murphy said: “I don’t have the details.”
“She was in South Africa and she is somehow in New Jersey,” he said.
Murphy said it took “some time” for the results of the test on the woman to come back because testing the variant is “more complicated to sequence.”
RELATED: N.J. has its first omicron case. Here’s what we know as the COVID variant arrives.
This comes as COVID-19 cases and hospitalizations are on the rise again in New Jersey as the state continues to deal with the delta variant of the virus.
The state on Saturday reported another 18 deaths and 3,634 cases. The state’s seven-day average for new positive tests increased to 2,779, up 55% from a week ago and more than double the average (up 161%) from a month ago. That’s also the highest average since April 22. By comparison, however, the seven-day average was 4,367 on Dec. 4, 2020, when vaccinations were not yet available.
There were 1,118 patients hospitalized with confirmed or suspected coronavirus cases across New Jersey’s 71 hospitals as of Thursday night. It was the fifth straight day the state reported more than 1,000 hospitalizations.
Officials said they expected cases to keep rising with colder weather and holiday events.
Murphy said Tuesday there are no immediate plans for more lockdowns or other restrictions in New Jersey amid concerns over omicron. But the governor stressed things could change as the nation learns more about the variant.
CORONAVIRUS RESOURCES: Live map tracker | Newsletter| Homepage
Omicron is the latest strain of COVID-19 to spread across the globe. The World Health Organization designated omicron a “variant of concern,” saying it poses a “very high” global risk.
President Joe Biden this week called omicron “a cause for concern, not a cause for panic” as he laid out the steps the country is taking to combat the variant.
It was first identified in South Africa and has since spread to more than 20 countries, in Africa, Asia, Europe, and North America.
The United States’ first case was found this week in California. Locally, multiple cases have been identified in New York City, and Pennsylvania reported its first case Friday, in Philadelphia. The variant has also been found in Colorado, Hawaii, and Minnesota.
It is also unclear so far how well vaccines work against the variant. Moderna said this week it could have a booster shot to target omicron ready for approval by March 2022.
The U.S. Centers for Disease Control and Prevention said Thursday it expects the vaccines will “continue to offer protection against hospitalization and death” even against omicron, though the mutations in the variant will likely result in “significant reductions” in the ability of some antibodies from the vaccines or a prior coronavirus infection to battle the variant.
The CDC announced this week that every American adult should receive a vaccine booster shot if eligible because of the strain’s threat.